Author

Kathryn Lea Sewell

Observed names: K L Sewell, K Sewell, K. L. Sewell, K. Lea Sewell, K. Sewell, K.L Sewell, K.L. Sewell, K.Lea Sewell, Kathryn L. Sewell, Kathryn Sewell, Sewell, K.

Institution: Pfizer (United States)

Observed institutions: Albert Einstein College of Medicine, Beth Israel Deaconess Medical Center, Montefiore Medical Center, The University of Texas MD Anderson Cancer Center, Harvard University, Pfizer (United States), Genentech, Royal Brisbane and Women's Hospital, Sheba Medical Center, Ionis Pharmaceuticals (United States)

OpenAlex ID: A5111543477

Effects of Oral Administration of Type II Collagen on Rheumatoid Arthritis

1993 · David E. Trentham, Roselynn A. Dynesius-Trentham, et al. · Science · 618

Risedronate therapy prevents corticosteroid-induced bone loss : A twelve-month, multicenter, randomized, double-blind, placebo-controlled, parallel-group study

1999 · Stanley Cohen, Robert M. Levy, et al. · Arthritis & Rheumatism · 608

Phase 1 Study of Anti-CTGF Monoclonal Antibody in Patients with Diabetes and Microalbuminuria

2010 · Sharon G. Adler, Sherwyn Schwartz, et al. · Clinical Journal of the American Society of Nephrology · 206

Pathogenesis of rheumatoid arthritis

1993 · K.L. Sewell, D.E. Trentham · The Lancet · 131

Phase I Trial of ISIS 104838, a 2′-Methoxyethyl Modified Antisense Oligonucleotide Targeting Tumor Necrosis Factor-α

2002 · K. Lea Sewell, Richard S. Geary, et al. · Journal of Pharmacology and Experimental Therapeutics · 122

Suppression of collagen‐induced arthritis through adenovirus‐mediated transfer of a modified tumor necrosis factor α receptor gene

1997 · Christine H. Le, A. Graham Nicolson, et al. · Arthritis & Rheumatism · 101

Dose ranging pharmacokinetic trial of high‐dose alicaforsen (intercellular adhesion molecule‐1 antisense oligodeoxynucleotide) (ISIS 2302) in active Crohn's disease

2002 · B. R. Yacyshyn, C. Barish, et al. · Alimentary Pharmacology & Therapeutics · 69

A randomized controlled trial comparing PF-06438179/GP1111 (an infliximab biosimilar) and infliximab reference product for treatment of moderate to severe active rheumatoid arthritis despite methotrexate therapy

2018 · Stanley B. Cohen, Rieke Alten, et al. · Arthritis Research & Therapy · 65

PDF

Interleukin‐2 diphtheria fusion protein (dab486il‐2) in refractory rheumatoid arthritis a double‐blind, placebo‐controlled trial with open‐label extension

1995 · Larry W. Moreland, K. Lea Sewell, et al. · Arthritis & Rheumatism · 61

A comparative clinical study of PF-06410293, a candidate adalimumab biosimilar, and adalimumab reference product (Humira®) in the treatment of active rheumatoid arthritis

2018 · Roy M. Fleischmann, Rieke Alten, et al. · Arthritis Research & Therapy · 54

PDF

DAB486IL‐2 fusion toxin in refractory rheumatoid arthritis

1993 · Kathryn Lea Sewell, Karen C. Parker, et al. · Arthritis & Rheumatism · 51

Infliximab vs. adalimumab in Crohn's disease: results from 327 patients in an Australian and New Zealand observational cohort study

2016 · J. D. Doecke, F. Hartnell, et al. · Alimentary Pharmacology & Therapeutics · 48

PDF

2016 · Ira Jacobs, Danielle Petersel, et al. · BioDrugs · 47

PDF

Biosimilars Have Arrived: Rituximab

2018 · Maria Greenwald, John Tesser, et al. · Arthritis · 44

PDF

The Effect of Minocycline in Rat Models of Inflammatory Arthritis: Correlation of Arthritis Suppression with Enhanced T Cell Calcium Flux

1996 · K.Lea Sewell, Ferdinand Breedveld, et al. · Cellular Immunology · 42

Magnetic resonance imaging versus computed tomographic scanning in neuropsychiatric systemic lupus erythematosus

1989 · K.Lea Sewell, Avi Livneh, et al. · The American Journal of Medicine · 27

Prediction of Clinical Responses in a Simulated Phase III Trial of Crohn's Patients Administered the Antisense Phosphorothioate Oligonucleotide ISIS 2302: Comparison of Proposed Dosing Regimens

2003 · Rosie Z. Yu, John Q. Su, et al. · Antisense and Nucleic Acid Drug Development · 25

2017 · Daniel M. Geynisman, Guillermo De Velasco, et al. · Postgraduate Medicine · 14

Misdiagnosis of Rheumatoid Arthritis in an Elderly Woman with Gout

1991 · Kathryn Lea Sewell, Richard Petrucci, et al. · Journal of the American Geriatrics Society · 14

Osteoporosis therapies for rheumatoid arthritis patients: Minimizing gastrointestinal side effects

2001 · Kathryn Sewell, Jeffrey R. Schein · Seminars in Arthritis and Rheumatism · 12

Multisystem disease in post-streptococcal arthritis.

1991 · A Livneh, K Sharma, et al. · Annals of the Rheumatic Diseases · 10

PDF

Modern Therapeutic Approaches to Osteoporosis

1989 · Kathryn Lea Sewell · Rheumatic Disease Clinics of North America · 9

Clinical trial: endoscopic evaluation of naproxen etemesil, a naproxen prodrug, vs. naproxen – a proof‐of‐concept, randomized, double‐blind, active‐comparator study

2010 · J. L. Goldstein, A. Jungwirthová, et al. · Alimentary Pharmacology & Therapeutics · 8

PDF

Gene polymorphisms and serological markers of patients with active Crohn's disease in a clinical trial of antisense to ICAM-1

2005 · B R Yacyshyn, A Schievella, et al. · Clinical & Experimental Immunology · 8

Chronic gonococcal arthritis.

1989 · A Livneh, K L Sewell, et al. · PubMed · 8

Works count: 55

Citation count: 2,440

H-index: 17

I10-index: 21